Arrowhead Pharmaceuticals, Inc.
- Last sale
- Nov 12, 2026 · -4.50%
- Market cap
- $6.66B
- 141.37M shares
- Filings
- 1,014
FY 2026−45.6% FY26 yoy
FY 2026N/M FY26 yoy
FY 2026N/M FY26 yoy
FY 2026derivedN/M FY26 yoy
FY 2026N/M FY26 yoy
FY 2026−72.3% FY26 yoy
- $6.66B
- —
- 14.8×
- 132.4×
- -4.26%
- —
Twelve months to Sep 30, 2026 · derived
Price
Nov 12, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2026 | 2026-09-30 | $450,817,000 | reported | |
| FY 2025 | 2025-09-30 | $829,448,000 | reported | |
| FY 2024 | 2024-09-30 | $3,551,000 | reported | |
| FY 2023 | 2023-09-30 | $240,735,000 | reported | |
| FY 2022 | 2022-09-30 | $243,231,000 | reported | |
| FY 2021 | 2021-09-30 | $138,287,000 | reported | |
| FY 2020 | 2020-09-30 | $87,992,000 | reported | |
| FY 2019 | 2019-09-30 | $168,796,000 | reported | |
| FY 2018 | 2018-09-30 | $16,142,321 | reported | |
| FY 2017 | 2017-09-30 | $31,407,709 | reported | |
| FY 2016 | 2016-09-30 | $158,333 | reported | |
| FY 2015 | 2015-09-30 | $382,000 | reported |
Segments
Products
LineFY2026ShareChange
Collaboration and license revenue$444.21M99%−46.4%
Product revenue, net$6.60M1.5%—
Total$450.82M
Pharmaceutical preparations
Arrowhead Pharmaceuticals, Inc. is the 59th largest of the 552 covered companies the SEC files under this code, by revenue. SIC 2834
CompanyRevenueGrowthNet marginMarket cap
MIRMMirum Pharmaceuticals, Inc.Fiscal 2025 figures$521.3M54.7%4.5%$6.1BBBIOBridgeBio Pharma, Inc.Fiscal 2025 figures$502.1M126.3%144.4%$14.6BTVTXTravere Therapeutics, Inc.Fiscal 2025 figures$490.7M110.5%5.2%$5.0BNATRNatures Sunshine Products IncFiscal 2025 figures$480.1M5.7%4.1%$178.3MZLABZai Lab LtdFiscal 2025 figures$460.2M15.3%38.1%$29.3B
ARWRArrowhead Pharmaceuticals, Inc. (this company)$450.8M45.6%160.6%$6.7B
INVAInnoviva, Inc.Fiscal 2025 figures$411.3M14.7%65.9%$1.3BARDXArdelyx, Inc.Fiscal 2025 figures$407.3M22.1%15.1%$781.8MSVASinovac Biotech LtdFiscal 2025 figures$386.0M6.8%51.5%$464.9MPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
Arrowhead Pharmaceuticals, Inc. · CIK 879407 · Engraved from SEC EDGAR